IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.764
EU - Europa 32.939
AS - Asia 26.667
SA - Sud America 5.441
Continente sconosciuto - Info sul continente non disponibili 776
AF - Africa 663
OC - Oceania 140
Totale 119.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 49.760
SG - Singapore 9.650
GB - Regno Unito 7.263
RU - Federazione Russa 7.236
IT - Italia 7.037
CN - Cina 6.688
BR - Brasile 4.232
VN - Vietnam 3.666
UA - Ucraina 2.336
DE - Germania 2.309
CA - Canada 2.253
HK - Hong Kong 1.972
BD - Bangladesh 1.754
DK - Danimarca 1.529
FR - Francia 1.129
SE - Svezia 1.011
FI - Finlandia 840
IN - India 567
IE - Irlanda 550
PL - Polonia 538
MX - Messico 478
AR - Argentina 437
NL - Olanda 385
TR - Turchia 328
IL - Israele 279
ID - Indonesia 253
EC - Ecuador 225
IQ - Iraq 214
ZA - Sudafrica 212
PK - Pakistan 209
JP - Giappone 204
ES - Italia 190
CO - Colombia 144
VE - Venezuela 118
AT - Austria 114
EU - Europa 106
AU - Australia 104
UZ - Uzbekistan 100
MA - Marocco 99
SA - Arabia Saudita 90
CL - Cile 87
KR - Corea 77
IR - Iran 72
AE - Emirati Arabi Uniti 70
EG - Egitto 67
MY - Malesia 67
PY - Paraguay 67
KE - Kenya 64
LT - Lituania 62
PH - Filippine 61
PE - Perù 57
TN - Tunisia 52
RO - Romania 48
JM - Giamaica 47
JO - Giordania 46
CR - Costa Rica 45
CH - Svizzera 41
DZ - Algeria 41
BE - Belgio 40
NP - Nepal 38
HN - Honduras 36
PT - Portogallo 36
BO - Bolivia 34
NZ - Nuova Zelanda 33
UY - Uruguay 33
SK - Slovacchia (Repubblica Slovacca) 32
AZ - Azerbaigian 31
TH - Thailandia 31
CZ - Repubblica Ceca 30
ET - Etiopia 30
GR - Grecia 23
KZ - Kazakistan 23
TT - Trinidad e Tobago 22
TW - Taiwan 22
GT - Guatemala 20
DO - Repubblica Dominicana 19
NI - Nicaragua 19
KG - Kirghizistan 18
PS - Palestinian Territory 17
AL - Albania 16
HU - Ungheria 16
OM - Oman 16
PA - Panama 16
QA - Qatar 15
GE - Georgia 13
AM - Armenia 12
LV - Lettonia 12
NO - Norvegia 12
RS - Serbia 12
BY - Bielorussia 11
MK - Macedonia 11
SN - Senegal 11
SV - El Salvador 11
BB - Barbados 10
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
BA - Bosnia-Erzegovina 9
Totale 118.520
Salva come PNG Salva come JPEG
Città #
Dallas 8.067
Southend 4.837
Singapore 4.822
Ashburn 3.172
San Jose 3.042
Beijing 2.758
Woodbridge 2.675
Chandler 2.320
Ann Arbor 2.295
Houston 2.112
Hong Kong 1.752
Fairfield 1.626
San Mateo 1.470
Moscow 1.304
Falls Church 1.263
Jacksonville 1.110
Seattle 1.093
Los Angeles 1.061
Dearborn 1.020
Milan 1.001
Ho Chi Minh City 999
Cambridge 969
Wilmington 898
Ottawa 865
The Dalles 795
New York 759
Rome 681
Chicago 658
Pisa 649
Hanoi 633
Santa Clara 565
Hefei 542
Boardman 541
Dublin 522
Lauterbourg 513
Stevenage 512
Portsmouth 502
Council Bluffs 495
Warsaw 492
Dong Ket 483
São Paulo 458
Buffalo 440
Helsinki 426
Montréal 403
Lawrence 385
Brooklyn 323
Beauharnois 315
London 258
Tel Aviv 251
Munich 247
Orem 244
Salt Lake City 229
Mexico City 212
Florence 207
Montreal 207
Frankfurt am Main 183
San Diego 176
Redwood City 175
Tokyo 165
Old Bridge 158
Denver 157
Columbus 155
Stockholm 152
Toronto 152
Chennai 150
Istanbul 149
Atlanta 147
Rio de Janeiro 145
Poplar 141
Figino 140
Amsterdam 134
Da Nang 134
Johannesburg 134
Phoenix 131
Haiphong 120
Tampa 114
Elk Grove Village 112
Fremont 111
Boston 110
Naples 110
Nuremberg 108
Turin 107
Bologna 97
Manchester 95
Tashkent 90
San Francisco 89
Ankara 78
Biên Hòa 74
Belo Horizonte 73
Mumbai 73
Washington 73
Brasília 71
Curitiba 71
Shanghai 71
Guayaquil 69
Turku 69
Baghdad 68
Norwalk 68
Paris 68
Quito 68
Totale 71.613
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.706
Value in Healthcare and the Role of the Patient Voice 1.215
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 697
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 619
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 614
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 513
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 507
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 490
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 485
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 454
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 449
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 424
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 401
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 400
A simple echocardiographic score to rule out cardiac amyloidosis 391
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 384
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 373
Human pathophysiological adaptations to the space environment 368
A simple echocardiographic score to rule out cardiac amyloidosis 364
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 359
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 358
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 356
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 352
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 347
The evolution of TAVI performance overtime: an overview of systematic reviews 345
La neuropatia diabetica 342
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 340
[Central apneas and cardiovascular diseases] 339
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 338
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 335
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 335
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 334
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 333
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 332
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 332
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 332
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 332
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 331
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 331
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 330
Prediction of the chemoreflex gain by common clinical variables in heart failure 330
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 330
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 330
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 329
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 328
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 327
Treating chemoreflex in heart failure: modulation or demolition? 327
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 326
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 324
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 321
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 319
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 317
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 317
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 316
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 316
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 314
Adrenergic activation in heart failure: blockade or rebalance? 313
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 311
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 309
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 309
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 306
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 305
Eligibility for vericiguat in a real‐world, contemporary heart failure population 304
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 304
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 304
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 303
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 303
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 303
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 301
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 301
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 301
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 300
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 297
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 296
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 296
Screening the health status of people working in a university 295
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 294
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 294
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 293
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 293
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 293
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 292
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 291
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 289
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 289
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 289
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 288
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 287
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 287
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 286
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 285
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 285
How to take arms against central apneas in heart failure 285
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 285
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 282
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 282
Sex-related differences in chronic heart failure 281
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 280
Totale 36.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 591.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 591.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.450 0 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202651.227 2.676 8.082 5.678 6.166 5.331 3.021 5.769 2.122 2.720 3.260 3.163 3.239
2026/20271.353 1.328 25 0 0 0 0 0 0 0 0 0 0
Totale 119.390